Xeljanz Doesn't Increase Cancer Risk in RA Patients (CME/CE)
(MedPage Today) -- Rates were within expected range for moderate-to-severe rheumatoid arthritis.
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Arthritis | Cancer | Cancer & Oncology | Geriatrics | Rheumatoid Arthritis | Rheumatology